(Circulation. 1999;99:420-426.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
Interleukin-8 Mediates Downregulation of Tissue Inhibitor of Metalloproteinase-1 Expression in Cholesterol-Loaded Human Macrophages
Relevance to Stability of Atherosclerotic Plaque
From Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 321 "Lipoproteins and Atherogenesis" (M.M., L.P., M.J.C., M.R.); Service d'Anatomo-Pathologie, Hôpital de la Pitié-Salpêtrière (I.B.); and Institut Federatif de Recherche sur la Physiopathologie et Génétique Cardiovasculaire, Hôpital de la Pitié-Salpêtrière, Université Pierre et Marie Curie (M.M., I.B., L.P., E.N., J.C., M.R.), Paris, France.
Correspondence to Mustapha Rouis, PhD, INSERM U-321 Pavillon Benjamin Delessert, Hôpital de la Pitié-Salpêtrière, 83 Bd de l' Hôpital, 75651 Paris Cedex 13, France.. E-mail rouis{at}infobiogen.fr
Background—The accumulation of macrophage-derived foam cells in atherosclerotic lesions correlates with increased local release of matrix-degrading metalloproteinases (MMPs) and a thin fibrous cap. The activity of these enzymes is controlled by specific tissue inhibitors of metalloproteinases (TIMPs).
Methods and Results—Because oxidized low-density lipoprotein
(OxLDL) modulates gene expression, we investigated the effect of these
particles on the levels of MMP-1, MMP-3, MMP-9, TIMP-1, and TIMP-2 in
the culture media of human monocyte-derived macrophages. OxLDL
but not native LDL or high-density lipoprotein reduced the level of
TIMP-1 in a dose-dependent manner with maximal effect (60% of control)
at 
100 µg protein/mL. In addition, Northern blotting revealed
marked reduction in the abundance of TIMP-1 mRNA in OxLDL-treated
cells. Evaluation of the effect of oxysterol components of OxLDL on
TIMP-1 production revealed that
25-hydroxycholesterol (1 µg/mL) was the most potent
inhibitor (30% of control). Such inhibition was
partially mediated by interleukin (IL)-8. Indeed, IL-8 (2.5 ng/mL)
induced maximal inhibition of TIMP-1 accumulation (30% of control) in
4 of 6 cell preparations. In addition, the inhibitory
effect of OxLDL-treated cells in the presence of an anti–IL-8
neutralizing antibody was partially reversed.
Conclusions—Immunohistochemical analyses of human atherosclerotic plaques revealed the expression of TIMP-1 in some but not all macrophage-rich and IL-8–rich areas. Therefore, IL-8 may play a potential atherogenic role by inhibiting local TIMP-1 expression, thereby leading to an imbalance between MMPs and TIMPs at focal sites in the atherosclerotic plaque.
Key Words: atherosclerosis • lesions • interleukins • lipoproteins • plaque • metalloproteinases tissue inhibitor
This article has been cited by other articles:
 |
|
 |
|
  H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease Vascular Medicine, November 1, 2007; 12(4): 299 - 309. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Thalmann and C. A. Meier Local adipose tissue depots as cardiovascular risk factors Cardiovasc Res, September 1, 2007; 75(4): 690 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Segers, F. Helderman, C. Cheng, L. C.A. van Damme, D. Tempel, E. Boersma, P. W. Serruys, R. de Crom, A. F.W. van der Steen, P. Holvoet, et al. Gelatinolytic Activity in Atherosclerotic Plaques Is Highly Localized and Is Associated With Both Macrophages and Smooth Muscle Cells In Vivo Circulation, February 6, 2007; 115(5): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Schrijvers, G. R.Y. De Meyer, A. G. Herman, and W. Martinet Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability Cardiovasc Res, February 1, 2007; 73(3): 470 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Janssens and H. R. Lijnen What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models? Cardiovasc Res, February 15, 2006; 69(3): 585 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Holven, J. K. Damas, A. Yndestad, T. Waehre, T. Ueland, B. Halvorsen, L. Heggelund, W. J. Sandberg, A. G. Semb, S. S. Froland, et al. Chemokines in Children With Heterozygous Familiar Hypercholesterolemia: Selective Upregulation of RANTES Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 200 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kobashi, M. Urakaze, M. Kishida, E. Kibayashi, H. Kobayashi, S. Kihara, T. Funahashi, M. Takata, R. Temaru, A. Sato, et al. Adiponectin Inhibits Endothelial Synthesis of Interleukin-8 Circ. Res., December 9, 2005; 97(12): 1245 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Newby Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture Physiol Rev, January 1, 2005; 85(1): 1 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Fach, L.-A. Garulacan, J. Gao, Q. Xiao, S. M. Storm, Y. P. Dubaquie, S. A. Hefta, and G. J. Opiteck In Vitro Biomarker Discovery for Atherosclerosis by Proteomics Mol. Cell. Proteomics, December 1, 2004; 3(12): 1200 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Boekholdt, R. J. G. Peters, C. E. Hack, N. E. Day, R. Luben, S. A. Bingham, N. J. Wareham, P. H. Reitsma, and K.-T. Khaw IL-8 Plasma Concentrations and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1503 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Lindstedt, M. J. Leskinen, and P. T. Kovanen Proteolysis of the Pericellular Matrix: A Novel Element Determining Cell Survival and Death in the Pathogenesis of Plaque Erosion and Rupture Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1350 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Bruun, A. S. Lihn, A. K. Madan, S. B. Pedersen, K. M. Schiott, J. N. Fain, and B. Richelsen Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E8 - E13. [Abstract] [Full Text]
|
|
|
|
|
|
C. B Jones, D. C Sane, and D. M Herrington Matrix metalloproteinases: A review of their structure and role in acute coronary syndrome Cardiovasc Res, October 1, 2003; 59(4): 812 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Castoldi, C. R. T. di Gioia, F. Pieruzzi, C. D'Orlando, W. M. M. van de Greef, G. Busca, G. Sperti, and A. Stella ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H635 - H643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Straczkowski, S. Dzienis-Straczkowska, A. Stepien, I. Kowalska, M. Szelachowska, and I. Kinalska Plasma Interleukin-8 Concentrations Are Increased in Obese Subjects and Related to Fat Mass and Tumor Necrosis Factor-{alpha} System J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4602 - 4606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Salcedo, M. Martins-Green, B. Gertz, J. J. Oppenheim, and W. J. Murphy Combined Administration of Antibodies to Human Interleukin 8 and Epidermal Growth Factor Receptor Results in Increased Antimetastatic Effects on Human Breast Carcinoma Xenografts Clin. Cancer Res., August 1, 2002; 8(8): 2655 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Holven, P. Aukrust, T. Holm, L. Ose, and M. S. Nenseter Folic Acid Treatment Reduces Chemokine Release From Peripheral Blood Mononuclear Cells in Hyperhomocysteinemic Subjects Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 699 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Armstrong and E. B. Jude The Role of Matrix Metalloproteinases in Wound Healing J Am Podiatr Med Assoc, January 1, 2002; 92(1): 12 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bobik and N. Kalinina Tumor Necrosis Factor Receptor and Ligand Superfamily Family Members TNFRSF14 and LIGHT: New Players in Human Atherogenesis Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1873 - 1875. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Pollanen, P. J. Karhunen, J. Mikkelsson, P. Laippala, M. Perola, A. Penttila, K. M. Mattila, T. Koivula, and T. Lehtimaki Coronary Artery Complicated Lesion Area Is Related to Functional Polymorphism of Matrix Metalloproteinase 9 Gene: An Autopsy Study Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1446 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bruun, S. B. Pedersen, and B. Richelsen Regulation of Interleukin 8 Production and Gene Expression in Human Adipose Tissue in Vitro J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1267 - 1273. [Abstract] [Full Text]
|
|
|
|
 |
|
 P.a. Aukrust, R. K. Berge, T. Ueland, E. Aaser, J. K. Damas, L. Wikeby, A. Brunsvig, F. Muller, K. Forfang, S. S. Froland, et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes J. Am. Coll. Cardiol., February 1, 2001; 37(2): 485 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Holven, P. Aukrust, T. Holm, L. Ose, and M. S. Nenseter Folic Acid Treatment Reduces Chemokine Release From Peripheral Blood Mononuclear Cells in Hyperhomocysteinemic Subjects Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 699 - 703. [Abstract] [Full Text] [PDF]
|
|